Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation — Yulia A. Nevzorova (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation
RW
Shared by
Ralf Weiskirchen
Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation
Article
2023
en
Authors
YN
Yulia A. Nevzorova
RW
Ralf Weiskirchen
CL
Christian Liedtke
Related publications
Article
2016
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Hans-Theo Schon
,
Matthias Bartneck
,
Erawan Borkham‐Kamphorst
,
Jacob Nattermann
,
Twan Lammers
,
Frank Tacke
,
Ralf Weiskirchen
Article
2004
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Erawan Borkham‐Kamphorst
,
Jens Herrmann
,
Doris Stoll
,
Jens Treptau
,
Axel M. Gressner
,
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Human antigen R contributes to hepatic stellate cell activation and liver fibrosis.
Ralf Weiskirchen
,
Jens Herrmann
Article
2014
Hepatic stellate cell specific endoglin deletion modulates TGF-β signaling and aggravates liver fibrosis in two experimental models of murine liver injury
Muhammad Alsamman
,
Viktor Sterzer
,
Steffen K. Meurer
,
Hacer Sahin
,
Ralf Weiskirchen
,
Christian Trautwein
,
David Scholten
Preprint
2021
Commentary on: Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1 mediated deacetylation of GLI1 and hepatic stellate cell activation
Ralf Weiskirchen
Discussion(0)
No comments yet. Be the first to comment.